Additive genetic effect of APOE and BDNF on hippocampus activity

NeuroImage

Volumn 89, Issue , 2014, Pages 306-313

  Kauppi, Karolina ^a,e   Nilsson, Lars Göran ^b,c   Persson, Jonas ^a,c   Nyberg, Lars ^a,d,e  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d Stockholm Brain Institute   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

APOE; BDNF; FMRI; Gene gene effect; Hippocampus; Imaging genetics

Indexed keywords

APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ALLELE; APOE EPSILON 4 GENE; ARTICLE; BDNF GENE; BOLD SIGNAL; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE FUNCTION; GENE INTERACTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; HETEROZYGOTE; HIPPOCAMPUS; HOMOZYGOTE; HUMAN; KIBRA GENE; MALE; MEDIAL TEMPORAL LOBE; MEMORY; MEMORY DISORDER; MENTAL PERFORMANCE; PARAHIPPOCAMPAL GYRUS; POPULATION RESEARCH; PRIORITY JOURNAL; TEMPORAL LOBE; AGED; APOE GENE; BRAIN SIZE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN EXPERIMENT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PARAHIPPOCAMPUS;

APOE; BDNF; FMRI; GENE-GENE EFFECT; HIPPOCAMPUS; IMAGING GENETICS;

AGED; APOLIPOPROTEINS E; BRAIN MAPPING; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED;

EID: 84892892084     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.11.049     Document Type: Article

References (60)

1. Adamson M.M., Hutchinson J.B., Shelton A.L., Wagner A.D., Taylor J.L. Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE e4 allele. Neuropsychologia 2011, 49:2448-2455.
2. Ashburner J., Friston K.J. Unified segmentation. NeuroImage 2005, 26:839-851.
3. Bearden C.E., Karlsgodt K.H., Bachman P., Erp T.G.M.Van, Winkler A.M., David C., Glahn D.C. Genetic architecture of declarative memory: implications for complext illnesses. Neuroscientist 2012, 18:516-532.
4. Blacker D., Haines J., Rodes L., Terwedow H., Go R., Harrell L., Perry R., Bassett S., Chase G., Meyers D., Albert M., Tanzi R. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 1997, 48:139-147.
5. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 2000, 343:450-456.
6. Bretsky P., Guralnik J.M., Launer L., Albert M., Seeman T.E. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur studies of successful aging. Neurology 2003, 60:107.
7. Bueller J., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., Zubieta J. BDNF val(66) met allele is associated with reduced hippocampal volume in healthy subjects. Biol. Psychiatry 2006, 59:812-815. (7-1081).
8. Canli T., Congdon E., Todd Constable R., Lesch K.P. Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on neural correlates of affective processing. Biol. Psychol. 2008, 79:118-125.
9. Carr V.A., Viskontas I.V., Engel S.A., Knowlton B.J. Neural activity in the hippocampus and perirhinal cortex during encoding is associated with the durability of episodic memory. J. Cogn. Neurosci. 2009, 22(11):2652-2662.
10. Casanova R., Srikanth R., Baer A., Laurienti P.J., Burdette J.H., Hayasaka S., Flowers L., Wood F., Maldjian J.A. Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. NeuroImage 2007, 34:137-143.
11. Chen C.-H., Suckling J., Lennox B.R., Ooi C., Bullmore E.T. A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord. 2011, 13:1-15.
12. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.a Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 8:41-43.
13. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Rimmel J.B., Locke P.A., Conneally P.M., Schmader K.E., Small G.W., Roses A.D., Haines J., Pericak-Vance M.A. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimers disease. Nat. Genet. 1994, 7:180-184.
14. de Quervain D.J.-F., Papassotiropoulos A. Identification of a genetic cluster influencing memory performance and hippocampal activity in humans. PNAS 2006, 103:4270-4274.
15. Dik M.G., Deeg D.J., Bouter L.M., Corder E.H., Kok A., Jonker C. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: a population-based study. Stroke 2000, 31:2431-2436.
16. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
17. Eichenbaum H. Hippocampus: cognitive processes and neural representations that underlie declarative memory. Neuron 2004, 44:109-120.
18. Eichenbaum H., Yonelinas A.P., Ranganath C. The medial temporal lobe and recognition memory. Annu. Rev. Neurosci. 2007, 30:123-152.
19. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., Van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
20. Fehér A., Juhász A., Rimanóczy A., Kálmán J., Janka Z. Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease. Alzheimer Dis. Assoc. Disord. 2009, 23:224-228.
21. Fernández G., Weyerts H., Schrader-Bölsche M., Tendolkar I., Smid H.G., Tempelmann C., Hinrichs H., Scheich H., Elger C.E., Mangun G.R., Heinze H.J. Successful verbal encoding into episodic memory engages the posterior hippocampus: a parametrically analyzed functional magnetic resonance imaging study. J. Neurosci. 1998, 18:1841-1847.
22. Filippini N., MacIntosh B.J., Hough M.G., Goodwin G.M., Frisoni G.B., Smith S.M., Matthews P.M., Beckmann C.F., Mackay C.E. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. PNAS 2009, 106:7209-7214.
23. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
24. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
25. Han S.D., Houston W.S., Jak A.J., Eyler L.T., Nagel B.J., Fleisher A.S., Brown G.G., Corey-Bloom J., Salmon D.P., Thal L.J., Bondi M.W. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol. Aging 2007, 28:238-247.
26. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 2003, 23:6690-6694.
27. Hashimoto R., Moriguchi Y., Yamashita F., Mori T., Nemoto K., Okada T., Hori H., Noguchi H., Kunugi H., Ohnishi T. Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neurosci. Res. 2008, 61:360-367.
28. Herrmann M.J., Huter T., Müller F., Mühlberger A., Pauli P., Reif A., Renner T., Canli T., Fallgatter A.J., Lesch K.-P. Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on emotional processing. Cereb. Cortex 2007, 17:1160-1163.
29. Hong C.-J., Liou Y.-J., Tsai S.-J. Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res. Bull. 2011, 86:287-297.
30. Kambeitz J.P., Bhattacharyya S., Kambeitz-ilankovic L.M., Valli I., Collier D.A., Mcguire P. Effect of BDNF val 66 met polymorphism on declarative memory and its neural substrate: a meta-analysis. Neurosci. Biobehav. Rev. 2012, 36:2165-2177.
31. Kauppi K., Nilsson L.-G., Adolfsson R., Eriksson E., Nyberg L. KIBRA polymorphism is related to enhanced memory and elevated hippocampal processing. J. Neurosci. 2011, 31:14218-14222.
32. Kauppi K., Nilsson L.-G., Adolfsson R., Lundquist A., Eriksson E., Nyberg L. Decreased medial temporal lobe activation in BDNF (66)Met allele carriers during memory encoding. Neuropsychologia 2013, 51:2462-2468.
33. Li Y., Rowland C., Tacey K., Catanese J., Sninsky J., Hardy J., Powell J., Lovestone S., Morris J.C., Thal L., Goate A., Owen M., Williams J., Grupe A. The BDNF Val66Met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples. Mol. Psychiatry 2005, 10:809-810.
34. Lind J., Persson J., Ingvar M., Larsson A., Cruts M., Van Broeckhoven C., Adolfsson R., Bäckman L., Nilsson L.-G., Petersson K.M., Nyberg L. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Brain 2006, 129:1240-1248.
35. McClearn G.E., Johansson B., Berg S., Pedersen N.L., Ahern F., Petrill S.A., Plomin R. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 1997, 276:1560-1563.
36. Meyer-Lindenberg A. The future of fMRI and genetics research. NeuroImage 2012, 62:1286-1292.
37. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., Kennedy J.L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet. 2002, 71:651-655.
38. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., Sinclair M., Crombie C., Walker N., St Clair D.M. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 2005, 10:208-212.
39. Nilsson L.-G., Adolfsson R., Backman L., De Frias C., Molander B., Nyberg L. Betula: a prospective cohort study on memory, health and aging. Aging Neuropsychol. Cognit. 2004, 11:134-148.
40. Nilsson L.G., Adolfsson R., Bäckman L., Cruts M., Nyberg L., Small B.J., Van Broeckoven C. The influence of APOE status on episodic and semantic memory: data from a population-based study. Neuropsychology 2006, 20:645-657.
41. Papassotiropoulos A., de Quervain D.J. Genetics of human episodic memory: dealing with complexity. Trends Cogn. Sci. 2011, 987:1-7.
42. Persson J., Kalpouzos G., Nilsson L.-G., Ryberg M., Nyberg L. Preserved hippocampus activation in normal aging as revealed by fMRI. Hippocampus 2010, 21:753-766.
43. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2001, 2:24-32.
44. Rasch B., Pappassotiropoulos A., de Quervain D.-F. Imaging genetics of cognitive functions: focus on episodic memory. NeuroImage 2010, 53:870-877.
45. Richter-Schmidinger T., Alexopoulos P., Horn M., Maus S., Reichel M., Rhein C., Lewczuk P., Sidiropoulos C., Kneib T., Perneczky R., Doerfler A., Kornhuber J. Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. J. Neural Transm. 2011, 118:249-257.
46. Salami A., Eriksson J., Nyberg L. Opposing effects of aging on large-scale brain systems for memory encoding and cognitive control. J. Neurosci. 2012, 32:10749-10757.
47. Schott B.H., Seidenbecher C.I., Fenker D.B., Lauer C.J., Bunzeck N., Bernstein H.-G., Tischmeyer W., Gundelfinger E.D., Heinze H.-J., Düzel E. The dopaminergic midbrain participates in human episodic memory formation: evidence from genetic imaging. J. Neurosci. 2006, 26:1407-1417.
48. Small S.A., Perera G.M., DeLapaz R., Mayeux R., Stern Y. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann. Neurol. 1999, 45:466-472.
49. Smith J.D. Apolipoproteins and aging: emerging mechanisms. Ageing Res. Rev. 2002, 1:345-365.
50. Smolka M.N., Bühler M., Schumann G., Klein S., Hu X.-Z., Moayer M., Zimmer A., Wrase J., Flor H., Mann K., Braus D.F., Goldman D., Heinz A. Gene-gene effects on central processing of aversive stimuli. Mol. Psychiatry 2007, 12:307-317.
51. Trachtenberg A.J., Filippini N., Mackay C.E. The effects of APOE-epsilon4 on the BOLD response. Neurobiol. Aging 2012, 33:323-334.
52. Trivedi M.A., Schmitz T.W., Ries M.L., Torgerson B.M., Sager M.A., Hermann B.P., Asthana S., Johnson S.C. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study. BMC Med. 2006, 4:1.
53. Ventriglia M., Bocchio Chiavetto L., Benussi L., Binetti G., Zanetti O., Riva M., Gennarelli M. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's. Mol. Psychiatry 2002, 7:136-139.
54. Verghese P.B., Castellano J.M., Holtzman D.M. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 2011, 10:241-252.
55. Wagner A.D., Schacter D.L., Rotte M., Koutstaal W., Maril A., Dale A.M., Rose B.R., Buckner R.L. Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. Science 1998, 281:1188-1191.
56. Wagner D., Koutstaal W., Schacter D.L. When encoding yields remembering: insights from event-related neuroimaging. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1999, 354:1307-1324.
57. Wais P.E. FMRI signals associated with memory strength in the medial temporal lobes: a meta-analysis. Neuropsychologia 2008, 46:3185-3196.
58. Weinberger D.R. Cell biology of the hippocampal formation in schizophrenia. Biol. Psychiatry 1999, 45:395-402.
59. Wilson P., Schaefer E., Larson M., Ordovas J. Apolipoprotein E alleles and risk of coronary disease-a meta-analysis. Arterioscler. Thromb. Vasc. Biol. 1996, 16:1250-1255.
60. Wisdom N.M., Callahan J.L., Hawkins K.A. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol. Aging 2011, 32:63-74.